2026. A RANDOMIZED, OPEN-LABEL, PARALLEL, PROSPECTIVE STUDY COMPARING THE EFFECTIVENESS AND TOLERABILITY OF DULOXETINE, SERTRALINE, AND ESCITALOPRAM IN TREATING MAJOR DEPRESSIVE DISORDER. Asian Journal of Medical Research and Health Sciences (A-JMRHS). 4, 1 (Feb. 2026), 203–208. DOI:https://doi.org/10.65605/.